South Africa, Eswatini and Zambia launched the first public distribution of lenacapavir, a revolutionary HIV prevention injection that has been shown to reduce the risk of transmission by over 99.9 percent. The rollout, backed by global health agencies and targeting regions with the world’s highest rates of HIV infection, marks a major step forward in HIV prevention, even as advocates call for wider access and lower costs.
Source link
